Correction: Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib
Oncotarget
.
2019 Jan 4;10(2):254.
doi: 10.18632/oncotarget.26577.
Authors
Bin Zhao
1
,
Hong Zhao
1
2
Affiliations
1
Center for Scientific Research, The Second Affiliated Hospital & Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, 325027, China.
2
Department of Medical Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin, 150081, China.
PMID:
30719220
PMCID:
PMC6349436
DOI:
10.18632/oncotarget.26577
Abstract
[This corrects the article DOI: 10.18632/oncotarget.21217.].
Publication types
Published Erratum